[{"Year":2016,"Value":22.7,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2017,"Value":24.9,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2018,"Value":20.2,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2019,"Value":20.34,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2020,"Value":23.46,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2021,"Value":28.85,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested"},{"Year":2016,"Value":18.0,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"},{"Year":2017,"Value":25.8,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"},{"Year":2018,"Value":16.3,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"},{"Year":2019,"Value":10.55,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"},{"Year":2020,"Value":23.21,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"},{"Year":2021,"Value":20.83,"UNIT_MEASURE":"Percent","SERIES":"Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested"}]